FrancophonIA/ELRC3.0 huggingface dataset:
English: In the event of recurrence of ANC < 1.0 x109/l and/or platelets < 50 x 109/l, repeat step 1 and resume imatinib at reduced dose of 260 mg/m2.
Slovenian: 109/l in/ali koncentracija trombocitov < 50 x 109/l ponovi/ta, ponovite točko 1 in spet začnite zdravljenje z imatinibom z zmanjšanim odmerkom 260 mg/m2.
English: Hypokalaemia, increased appetite, hypophosphataemia, decreased appetite, dehydration, gout, hyperuricaemia, hypercalcaemia,
Slovenian: hipokaliemija, povečan apetit, hipofosfatemija,
English: Printing ink Shellac
Slovenian: PDGFR protein tirozin kinazami.
English: The increase in mean AUC with increasing dose was linear and dose proportional in the range of 25-1,000 mg imatinib after oral administration.
Slovenian: Plazemska farmakokinetika Po peroralnem dajanju zdravim prostovoljcem je bil t1/2 približno 18 ur, kar kaže na ustreznost enega odmerka na dan. Zvečevanje povprečne AUC z večanjem odmerka je bilo po peroralnem dajanju linearno in sorazmerno odmerku v območju 25-1000 mg imatiniba.
English: NAME OF THE MEDICINAL PRODUCT Imatinib Teva 400 mg hard capsules imatinib
Slovenian: NAVODILO ZA UPORABO Imatinib Teva 400 mg trde kapsule imatinib
English: Stomatitis, mouth ulceration, gastrointestinal haemorrhage7, eructation, melaena, oesophagitis, ascites, gastric ulcer, haematemesis, cheilitis, dysphagia, pancreatitis
Slovenian: stomatitis, razjede ustne sluznice, krvavitev iz prebavil7, spahovanje, melena, ezofagitis, ascites,
English: • Painful and/or blistering skin lesions.
Slovenian: • boleče spremembe na koži z ali brez nastanka mehurjev,
English: You may feel dizzy or drowsy or get blurred vision while taking this medicine.
Slovenian: V času jemanja zdravila Imatinib Teva lahko postanete omotični ali zaspani ali se vam zamegli vid.
English: DAUN (45 mg/m2/day bolus, IV): days 1 and 2
Slovenian: ): 1., 8. in 15. dan DAUN (45 mg/m2/dan bolus, i.v.
English: Chronic phase CML is defined when all of the following criteria are met: blasts < 15% in blood and
Slovenian: Pospešeno fazo opredeljuje eno ali več sledečih meril: blasti v krvi ali kostnem mozgu ≥ 15 %, vendar
English: Cytogenetic response Major response n (%) [95% CI] Complete CyR n (%)
Slovenian: Citogenetični odziv bolniki s pomembnim odzivom, število (%) [95 % interval zaupanja] bolniki s popolnim citogenetičnim odzivom, število bolniki z delnim citogenetičnim odzivom, število
English: DEX (6 mg/m2/day PO): days 1-5; 29-33 6-MP (75 mg/m2/day, PO): days 8-28
Slovenian: ): 1. in 29. dan DEX (6 mg/m2/dan, peroralno): 1.-5. dan in 29.-33. dan 6-MP (75 mg/m2/dan, peroralno: 8.-28. dan metotreksat (20 mg/m2/teden, peroralno):8., 15. in 22. dan VP-16 (100 mg/m2 i.v.
English: NAME OF THE MEDICINAL PRODUCT Imatinib Teva 100 mg film-coated tablets imatinib
Slovenian: NAVODILO ZA UPORABO Imatinib Teva 100 mg filmsko obložene tablete imatinib
English: AST: any
Slovenian: ): 4. dan
English: Three (3) patients with HES and CEL associated with PDGFR gene re-arrangements were reported in 3 publications.
Slovenian: publikacijah so objavljeni podatki treh (3) bolnikov s HES in CEL s preureditvijo gena za PDGFR.
English: penicillin V) only erythromycin (IC50 50 μM) and fluconazole (IC50 118 μM) showed inhibition of imatinib metabolism which could have clinical relevance.
Slovenian: Od skupine možnih zdravil za sočasno uporabo (paracetamol, aciklovir, alopurinol, amfotericin, citarabin, eritromicin, flukonazol, hidroksisečnina, norfloksacin, penicilin V) sta samo eritromicin (IC50 50 μM) in flukonazol (IC50 118 μM) pokazala inhibicijo presnove imatiniba, ki bi bila lahko klinično pomembna.
English: NAME OF THE MEDICINAL PRODUCT Imatinib Teva 100 mg film-coated tablets Imatinib Teva 400 mg film-coated tablets
Slovenian: Imatinib Teva 100 mg filmsko obložene tablete Imatinib Teva 400 mg filmsko obložene tablete
English: 8 Some fatal cases of hepatic failure and of hepatic necrosis have been reported.
Slovenian: Poročali so o nekaj primerih odpovedi jeter in nekroze jeter s smrtnim izidom.
English: During treatment with Imatinib Teva, tell your doctor straight away if you put on weight very quickly.
Slovenian: Če med jemanjem zdravila Imatinib Teva začnete hitro pridobivati telesno maso, takoj obvestite zdravnika.
English: 1200 mg to 1600 mg (duration varying between 1 to 10 days): Nausea, vomiting, diarrhoea, rash, erythema, oedema, swelling, fatigue, muscle spasms, thrombocytopenia, pancytopenia, abdominal pain, headache, decreased appetite.
Slovenian: Odrasla populacija Odmerki od 1200 mg do 1600 mg (trajanje zdravljenja od 1 do 10 dni): navzea, bruhanje, driska,
English: This change is not thought to be clinically significant.
Slovenian: Navedba smiselno ni potrebna.
English: - If you are being treated for CML: Depending on your condition the usual starting dose is either 400 mg or 600 mg: 400 mg to be taken as 1 capsule once a day, 600 mg to be taken as 1 capsule of 400 mg plus 2 capsules of 100 mg once a day.
Slovenian: - 400 mg vzamete kot 1 kapsulo enkrat na dan, 600 mg vzamete kot 1 kapsulo po 400 mg in še 2 kapsuli po 100 mg enkrat na dan.
English: Pack sizes of 60 or 120 film-coated tablets in blisters.
Slovenian: Škatle, ki vsebujejo po 30 ali 90 filmsko obloženih tablet v pretisnem omotu.
English: monthly for 13 months; Prednisolone 200 mg oral, 5 days per month for 13 months All treatment regimens include administration of steroids for CNS prophylaxis.
Slovenian: prednizolon 200 mg peroralno, 5 dni na mesec v obdobju 13 mesecev
English: ARA-C (3 g/m2/dose q 12 h x 4, IV): days 2 and 3 G-CSF (5 μg/kg, SC): days 4-13 or until ANC > 1500 post nadir
Slovenian: in 3. dan G-CSF (5 μg/kg, s.c.): 4.-13. dan oziroma do ANC > 1500 po doseženem najnižjem številu
English: Pruritus, face oedema, dry skin, erythema, alopecia, night sweats, photosensitivity reaction
Slovenian: pruritus, edem obraza, suha koža, eritem,
English: NAME OF THE MEDICINAL PRODUCT Imatinib Teva 400 mg film-coated tablets imatinib
Slovenian: NAVODILO ZA UPORABO Imatinib Teva 400 mg filmsko obložene tablete imatinib
English: Clinical studies in chronic myeloid leukaemia
Slovenian: Za otroke s kronično fazo KML
English: Daunorubicin 45 mg/m2 i.v., days 6-7, 13-14
Slovenian: daunorubicin 30 mg/m2 i.v., 1.-3., 15.-16. dan;
English: bone marrow, peripheral blood basophils < 20%, platelets > 100 x 10
Slovenian: < 30 %, blasti in promielociti skupaj ≥ 30 % v krvi ali kostnem mozgu (pogoj: blasti < 30 %), bazofilci v periferni krvi ≥ 20 %, trombociti < 100 x 10
English: Neutropenia, thrombocytopenia, anaemia
Slovenian: nevtropenija, trombocitopenija, anemija pogosti:
English: ANC < 0.5 x 10
Slovenian: Če se pojav/a ANC < 1,0 x
English: In CML, cytopenias, particularly neutropenia and thrombocytopenia, have been a consistent finding in all studies, with the suggestion of a higher frequency at high doses ≥ 750 mg (phase I study).
Slovenian: Podatki kažejo, da so lahko citopenije pogostejše pri velikih odmerkih ≥ 750 mg (študija prve faze),
English: Breast-feeding
Slovenian: propilenglikol
English: 400 mg to be taken as 4 tablets once a day,
Slovenian: - 400 mg vzamete kot 4 tablete enkrat na dan, 600 mg vzamete kot 6 tablet enkrat na dan.
English: Titanium dioxide (E171) Iron oxide, yellow (E172) Iron oxide, red (E172)
Slovenian: (E172), smukec, titanov dioksid (E171), rdeči železov oksid (E172).
English: Imatinib Teva is also a treatment for adults for: - Myelodysplastic/myeloproliferative diseases (MDS/MPD).
Slovenian: - z mielodisplastičnimi/mieloproliferativnimi boleznimi (MDS/MPD).
English: CPM (300 mg/m2/day, IV): days 22-26
Slovenian: ): 3. in 4. dan CPM (250 mg/m
English: If cytopenia persists for 4 weeks and is still unrelated to leukaemia, stop Imatinib until ANC ≥ 1 x 109/l and platelets ≥ 20 x 109/l, then resume treatment at 200 mg/m2.
Slovenian: dokler ni ANC ≥ 1 x 109/l in koncentracija trombocitov ≥ 20 x 109/l, nato spet začnite zdravljenje z odmerkom 200 mg/m2.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 100 mg of imatinib (as mesilate).
Slovenian: Ena filmsko obložena tableta vsebuje 100 mg imatiniba (v obliki mesilata).
English: G-CSF (5 μg/kg, SC): days 27-36 or until ANC > 1500 post nadir ARA-C (3 g/m2, q12h, IV): days 43, 44
Slovenian: G-CSF (5 μg/kg, s.c.): 27.-36. dan oziroma do ANC > 1500 po doseženem najnižjem številu
English: Pharmacokinetics in paediatric population
Slovenian: Posebne skupine bolnikov Uporaba v pediatriji
English: Hepatic failure8, hepatic necrosis Skin and subcutaneous tissue disorders Very common
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva zelo pogosti:
English: In the event of recurrence of ANC < 1.0 x109/l and/or platelets < 50 x 109/l, repeat step 1 and resume imatinib at reduced dose of 300 mg.
Slovenian: 109/l in/ali koncentracija trombocitov < 50 x 109/l ponovi/ta, ponovite točko 1 in spet začnite zdravljenje z imatinibom z zmanjšanim odmerkom 300 mg.
English: MESNA (360 mg/m2/dose q3h, x 8 doses/day, IV): days 1-5 G-CSF (5 μg/kg, SC): days 6-15 or until ANC > 1500 post nadir
Slovenian: ): 22.-26. dan G-CSF (5 μg/kg, s.c.):27.-36. dan oziroma do ANC > 1500 po doseženem najnižjem številu
English: VCR (1.5 mg/m2/day, IV): days 1, 8, and 15
Slovenian: VCR (1,5 mg/m2/dan, i.v.
English: MESNA (360 mg/m2/dose q3h, x 8 doses/day, IV): days 1-5 G-CSF (5 μg/kg, SC): days 6-15 or until ANC > 1500 post nadir IT Methotrexate (age-adjusted): day 1 ONLY Triple IT therapy (age-adjusted): day 8, 15
Slovenian: zdravljenje (prilagojeno na starost): 1. in 15. dan DEX (6 mg/m2/dan, peroralno): 1.-7. dan in 15.-21. dan 2. intenzifikacijski blok metotreksat (5 g/m2 v času 24 ur, i.v.
English: DEX 10 mg/m2 oral, days 1-5; CP 200 mg/m i.v., days 3, 4, 5; MTX 12 mg intrathecal, day 1
Slovenian: daunorubicin 30 mg/m2 i.v., 1.-3., 15.-16. dan; VCR skupni odmerek 2 mg i.v., 1., 8., 15., 22. dan; CP 750 mg/m2 i.v., 1., 8. dan;
English: Ara-C 1,000 mg/m2/12 h i.v.
Slovenian: ARA-C (3 g/m2, vsakih 12 ur, i.v.
English: Weight increased
Slovenian: Preveliko odmerjanje
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 400 mg of imatinib (as mesilate).
Slovenian: Ena filmsko obložena tableta vsebuje 400 mg imatiniba (v obliki mesilata).
English: Frequency categories are defined using the following convention: very common
Slovenian: Splošne težave in spremembe na mestu aplikacije zelo pogosti:
English: If cytopenia persists for 2 weeks, reduce further to 300 mg.
Slovenian: Če citopenija traja 2 tedna,
English: Dyspnoea, epistaxis, cough
Slovenian: disfagija, pankreatitis redki:
English: CPM (250 mg/m2/dose q12h x 4 doses, iv): Days 3 and 4 PEG-ASP (2500 IUnits/m2, IM): day 4
Slovenian: ): 1. in 2. dan CPM (250 mg/m2/odmerek vsakih 12 ur x 4 odmerki, i.v.
English: 600 mg to be taken as 6 capsules once a day.
Slovenian: - 400 mg vzamete kot 4 kapsule enkrat na dan, 600 mg vzamete kot 6 kapsul enkrat na dan.
English: Name and address of the manufacturers responsible for batch release Teva Czech Industries s.r.o.
Slovenian: Ime in naslov izdelovalca, odgovornega za sproščanje serije
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains 100 mg of imatinib (as mesilate).
Slovenian: Ena trda kapsula vsebuje 100 mg imatiniba (v obliki mesilata).
English: Eye irritation, eye pain, orbital oedema, scleral haemorrhage, retinal haemorrhage, blepharitis, macular oedema
Slovenian: draženje očesa, bolečine v očesu, orbitalni edem, krvavitev v beločnico, krvavitev v mrežnico,
English: Tumour haemorrhage/tumour necrosis* Immune system disorders Not known
Slovenian: sindrom tumorske lize pogostnost neznana:
English: Reproductive system and breast disorders Uncommon
Slovenian: Infekcijske in parazitske bolezni občasni:
English: Methotrexate (5 g/m over 24 hours, IV): day 1 Leucovorin (75 mg/m2 at hour 36, IV; 15 mg/m2 IV or PO q6h x 6
Slovenian: ): 1. in 15. dan levkovorin (75 mg/m2 36 ur po začetku, i.v.
English: Cardiac disorders Uncommon
Slovenian: glivične okužbe pogostnost neznana:
English: This summary was last updated on 22/04/2013.
Slovenian: Povzetek je bil nazadnje posodobljen dne 22/04/2013.
English: In very rare cases they may be serious or fatal.
Slovenian: V zelo redkih primerih so lahko resni ali smrtno nevarni.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Meloxidolor on 22/04/2013.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Meloxidolor, veljavno po vsej Evropski uniji, odobrila dne 22/04/2013.
English: It must not be used in cats weighing less than 2 kg.
Slovenian: Zdravilo se ne sme uporabljati pri mačkah, lažjih od 2 kg.
English: If someone accidentally injects themselves with the medicine, the advice of a doctor should be sought immediately.
Slovenian: Če si kdo po nesreči injicira to zdravilo, naj se takoj posvetuje z zdravnikom.
English: For meat the withdrawal period is 15 days and for milk it is five days.
Slovenian: Za meso je obdobje karence 15 dni, za mleko pa pet dni.
English: In dogs, these generally occur within the first week of treatment and usually disappear once treatment has stopped.
Slovenian: Pri psih se ti neželeni učinki v splošnem pojavijo v prvem tednu zdravljenja in po končanem zdravljenju običajno minejo.
English: For meat the withdrawal period is five days.
Slovenian: Za meso je obdobje karence pet dni.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) considered that, in accordance with European Union requirements, Meloxidolor has been considered to be bioequivalent to Metacam.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je menil, da je v skladu z zahtevami Evropske unije zdravilo Meloxidolor biološko enakovredno zdravilu Metacam.
English: As Meloxidolor is considered to be bioequivalent to the reference medicine, its benefit is taken as being the same as that of the reference medicine.
Slovenian: Ker je zdravilo Meloxidolor biološko enakovredno referenčnemu zdravilu, se njegove koristi obravnavajo kot enake koristim referenčnega zdravila.
English: Other information about Meloxidolor:
Slovenian: Druge informacije o zdravilu Meloxidolor:
English: People who are hypersensitive (allergic) to NSAIDs should avoid contact with Meloxidolor.
Slovenian: Osebe, ki so preobčutljive za (alergične na) nesteroidna protivnetna zdravila, naj se izogibajo stiku z zdravilom Meloxidolor.
English: Pregnant women and women of child-bearing potential should not administer Meloxidolor as meloxicam may be harmful for the foetus and unborn child.
Slovenian: Noseče ženske in ženske, ki bi lahko zanosile, naj zdravila Meloxidolor ne dajejo, ker je meloksikam lahko škodljiv za plod ali nerojenega otroka.
English: It is available as a solution for injection (5 mg/ml, 20 mg/ml and 40 mg/ml).
Slovenian: Na voljo je kot raztopina za injiciranje (5 mg/ml, 20 mg/ml in 40 mg/ml).
English: What benefit has Meloxidolor shown during the studies?
Slovenian: Kakšne koristi je zdravilo Meloxidolor izkazalo med študijami?
English: It is also the time allowed after administration of the medicine before the milk can be used for human consumption.
Slovenian: To je tudi čas, ki mora preteči po dajanju zdravila, preden se lahko mleko uporabi za prehrano ljudi.
English: In horses, a temporary swelling at the injection site can occur but resolves without intervention.
Slovenian: Pri konjih se lahko na mestu vboda pojavi začasna oteklina, ki mine brez intervencije.
English: It must not be used in animals which are hypersensitive (allergic) to the active substance or to any of the other ingredients.
Slovenian: Zdravilo se ne sme uporabljati pri živalih, ki so preobčutljive za (alergične na) zdravilno učinkovino ali katero koli drugo sestavino zdravila.
English: Meloxidolor meloxicam
Slovenian: Meloxidolor meloksikam
English: Meloxicam acts by blocking an enzyme called cyclo-oxygenase which is involved in the production of prostaglandins.
Slovenian: Meloksikam zavira encime, imenovane ciklooksigenaza, ki sodelujejo pri nastajanju prostaglandinov.
English: In very rare cases, potentially serious or fatal anaphylactoid reactions (similar to severe allergic reactions) may occur following administration of the solution for injection and should be treated symptomatically.
Slovenian: Zelo redko se lahko po dajanju raztopine za injiciranje pojavijo potencialno resne ali smrtno nevarne anafilaktoidne reakcije (podobne hudim alergičnim reakcijam), ki jih je treba zdraviti simptomatsko.
English: The product is not authorised for use in horses producing milk for human consumption.
Slovenian: Zdravilo ni dovoljeno za uporabo pri konjih v laktaciji, katerih mleko je namenjeno prehrani ljudi.
English: This means that Meloxidolor is similar to a ‘reference veterinary medicine' containing the same active substance, but it is also available at a higher strength.
Slovenian: To pomeni, da je podobno referenčnemu zdravilu za uporabo v veterinarski medicini, saj vsebuje enako zdravilno učinkovino, vendar je na voljo tudi v večji jakosti.
English: For intravenous use no studies in animals were needed as Meloxidolor contains the same active substance as the reference medicine Metacam.
Slovenian: Za intravenozno uporabo pri živalih niso bile potrebne nobene študije, saj zdravilo Meloxidolor vsebuje enako zdravilno učinkovino kot referenčno zdravilo Metacam.
English: As prostaglandins are substances that trigger inflammation, pain, exudation (fluid that leaks out of blood vessels during an inflammation) and fever, meloxicam reduces these signs of disease.
Slovenian: Ker so prostaglandini snovi, ki sprožajo vnetje, bolečino, izločanje tekočine (ki med vnetjem uhaja iz krvnih žil) in zvišano telesno temperaturo, meloksikam te bolezenske znake zmanjšuje.
English: Therefore the CVMP's view was that, as for Metacam, Meloxidolor's benefits are greater than its risks when used for the approved indications and the Committee recommended that Meloxidolor be given a marketing authorisation.
Slovenian: Zato je menil, da so njegove koristi, kot pri zdravilu Metacam, večje od z njim povezanih tveganj pri uporabi za odobrene indikacije, in priporočil, da se zanj odobri dovoljenje za promet.
English: What is the risk associated with Meloxidolor?
Slovenian: Kakšna tveganja so povezana z zdravilom Meloxidolor?
English: Meloxidolor contains meloxicam, which belongs to a class of medicines called non-steroidal antiinflammatory drugs (NSAIDs).
Slovenian: Zdravilo Meloxidolor vsebuje meloksikam, ki spada v skupino nesteroidnih protivnetnih zdravil (NSAID).
English: Meloxidolor must not be used in dogs, in cats or horses less than six weeks of age, in cattle less than one week of age when used in the treatment of diarrhoea or in pigs less than two days old.
Slovenian: Zdravilo Meloxidolor se ne sme uporabljati pri psih, mačkah ali konjih, mlajših od šest tednov, pri govedu, mlajšem od enega tedna, za zdravljenje driske, ali pri prašičih, mlajših od dveh dni.
English: It can be used in combination with oral re-hydration therapy for diarrhoea (medicines given by mouth to restore water levels in the body) in calves of over one week of age and in young, non-lactating cattle.
Slovenian: V kombinaciji s peroralnim rehidracijskim zdravljenjem driske (zdravili, ki se dajejo v usta za obnovitev ravni vode v telesu) se lahko uporablja pri teletih, starejših od enega tedna, in mladem govedu, ki ni v obdobju laktacije.
English: Meloxidolor is a medicine that contains the active substance meloxicam.
Slovenian: Meloxidolor je zdravilo, ki vsebuje zdravilno učinkovino meloksikam.
English: For subcutaneous and intramuscular use no studies were need for the 5 mg/ml and 20 mg/ml strengths as they contain the same concentration of active substance and have a similar composition to the reference product Metacam.
Slovenian: Za podkožno in intramuskularno uporabo za jakosti 5 mg/ml in 20 mg/ml niso bile potrebne nobene študije, saj vsebujejo enako koncentracijo zdravilne učinkovine in imajo podobno sestavo kot referenčno zdravilo Metacam.
English: Meloxidolor is a 'generic'.
Slovenian: Meloxidolor je generično zdravilo.
English: Meloxidolor must not be used in animals with liver, heart or kidney problems, bleeding disorders, or suffering from irritation or ulcers of the digestive tract.
Slovenian: Zdravila Meloxidolor ni dovoljeno uporabljati pri živalih s težavami z jetri, srcem ali ledvicami, krvavitvenimi motnjami ali pri živalih s težavami z draženjem ali razjedami prebavnega trakta.
English: Why has Meloxidolor been approved?
Slovenian: Zakaj je bilo zdravilo Meloxidolor odobreno?
English: While the reference medicine, Metacam, is available as 5 mg/ml and 20 mg/ml solutions for injection, Meloxidolor is also available as a 40 mg/ml solution for injection.
Slovenian: Medtem ko je referenčno zdravilo Metacam na voljo kot raztopina za injiciranje v jakosti 5 mg/ml in 20 mg/ml, je zdravilo Meloxidolor na voljo tudi kot raztopina za injiciranje v jakosti 40 mg/ml.
English: The 5 mg/ml solution for injection can also be used for the relief of post-operative pain associated with minor soft tissue surgery such as castration (surgical removal of the testicles) and the 20 mg/ml solution for injection can be used together with appropriate antibiotic therapy for the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia (bacteria present in blood) and toxaemia (a toxic state) (mastitis-metritis-agalactia syndrome).
Slovenian: Raztopina za injiciranje v jakosti 5 mg/ml se lahko uporablja tudi za lajšanje postoperativnih bolečin, povezanih z manjšimi operacijami mehkega tkiva (kirurško odstranitvijo mod), raztopina za injiciranje v jakosti 20 mg/ml pa se lahko ob ustreznem antibiotičnem zdravljenju uporablja za zdravljenje bolezni, ki nastanejo po prasitvi (kotitvi), na primer puerperalna septikemija (bakterija, ki je prisotna v krvi) in toksemija (toksično stanje) (sindrom mastitisa, metritisa in agalaktije).
English: Meloxidolor should not be used in pregnant or lactating dogs, cats and horses, but it can be used during pregnancy and lactation for cattle and pigs.
Slovenian: Zdravilo Meloxidolor se ne sme uporabljati pri psih, mačkah ali konjih v obdobju brejosti ali laktacije, lahko pa se v obdobju brejosti ali laktacije uporablja pri govedu in prašičih.
English: Meloxidolor solution for injection (5 mg/ml and 20 mg/ml) is used in pigs to reduce the symptoms of lameness (inability to walk normally) and inflammation in non-infectious locomotor disorders (diseases that affect the ability to move).
Slovenian: Meloxidolor raztopina za injiciranje (5 mg/ml in 20 mg/ml) se uporablja pri prašičih za ublažitev simptomov ohromelosti (nezmožnosti normalne hoje) in vnetja pri neinfekcijskih lokomotornih motnjah (boleznih, ki vplivajo na sposobnost premikanja).
English: Meloxidolor solution for injection (5 mg/ml) can be used to relieve inflammation and pain in dogs following surgery involving the bones or soft tissue (tissue just below the skin), and in cats following ovariohysterectomy (spaying) and minor soft tissue surgery.
Slovenian: Meloxidolor raztopina za injiciranje (5 mg/ml) se lahko uporablja pri psih za lajšanje vnetja in bolečin po operacijah kosti ali mehkega tkiva (tkivo tik pod kožo) ter pri mačkah po ovariohisterektomiji (steriliziranju) in manjših operacijah mehkega tkiva.
English: Meloxidolor solution for injection (20 mg/ml and 40 mg/ml) is used in horses to relieve colic (abdominal pain) and the inflammation and pain in musculo-skeletal disorders.
Slovenian: Meloxidolor raztopina za injiciranje (20 mg/ml in 40 mg/ml) se uporablja pri konjih za lajšanje kolik (bolečin v trebuhu) ter vnetja in bolečin pri kostno-mišično obolenjih.
English: Meloxidolor solution for injection (5 mg/ml, 20 mg/ml and 40 mg/ml) is used in cattle, together with appropriate antibiotic therapy, to reduce signs of disease in acute respiratory infections (infection of the lungs and airways).
Slovenian: Meloxidolor raztopina za injiciranje (5 mg/ml, 20 mg/ml in 40 mg/ml) se pri govedu ob ustreznem antibiotičnem zdravljenju uporablja za umirjanje znakov bolezni pri akutnih okužbah dihal (okužbah pljuč in dihalnih poti).
English: How has Meloxidolor been studied?
Slovenian: Kako je bilo zdravilo Meloxidolor raziskano?
English: What is Meloxidolor used for?
Slovenian: Za kaj se zdravilo Meloxidolor uporablja?